Sabra director granted 791 dividend stock units

Director Catherine Cusack received 791 additional stock units as dividend equivalents, bringing her reported direct stock unit holdings in SBRA to 82,847.

Rhea-AI Filing Summary

Sabra Health Care REIT, Inc. (SBRA) director Catherine Cusack reported an acquisition of 791 stock units of common stock on August 31, 2026, as a grant or award. The units were credited as dividend equivalent payments on previously granted stock units under Sabra’s 2009 Performance Incentive Plan.

After this credit, Cusack directly holds 82,847 stock units, including 7,027 unvested stock units and 47,553 vested stock units for which payment has been deferred. Each stock unit represents the right to receive one share of Sabra common stock.

Insider Trade Summary

Grant/Award: 791 shares

Grant/Award 1 txn

Insider Cusack Catherine

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1, F2	791	$0.00	$0.00

Holdings After Transaction: Common Stock — 82,847 shares (Direct)

Footnotes (2)

1. F1. Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate.
2. F2. Includes 7,027 unvested stock units and 47,553 stock units that have vested but the payment of which has been deferred. Each stock unit represents the right to receive one share of the Issuer's Common Stock.

Key Figures

Stock units granted: 791 stock units Holdings after transaction: 82,847 stock units Unvested stock units: 7,027 stock units +2 more

5 metrics

Stock units granted 791 stock units Grant/award credited on August 31, 2026 as dividend equivalent payments

Holdings after transaction 82,847 stock units Total direct stock units reported following the August 31, 2026 transaction

Unvested stock units 7,027 stock units Unvested portion of Cusack’s reported stock unit holdings

Vested but deferred stock units 47,553 stock units Vested stock units for which payment has been deferred

Transaction price per unit $0.00 per unit Reported price for the 791 stock units credited as dividend equivalent payments

Key Terms

dividend equivalent payments, stock units, 2009 Performance Incentive Plan

3 terms

dividend equivalent payments financial

"Represents stock units credited to the reporting person in the form of dividend equivalent payments"

stock units financial

"Includes 7,027 unvested stock units and 47,553 stock units that have vested"

Stock units are individual pieces of ownership in a company, like slices of a pie that together make up the whole business. They matter to investors because each unit represents a claim on the company’s assets, profits and sometimes voting power, and changes in the number or value of these units affect ownership percentages, potential dividends and share dilution — all of which influence an investment’s worth.

2009 Performance Incentive Plan financial

"outstanding under the Issuer's 2009 Performance Incentive Plan"

FAQ

What did Sabra Health Care REIT (SBRA) director Catherine Cusack report on this Form 4?

She reported a grant of 791 stock units of Sabra common stock on August 31, 2026, credited as dividend equivalent payments on previously granted stock units under Sabra’s 2009 Performance Incentive Plan.

How many SBRA stock units does Catherine Cusack hold after this transaction?

After the transaction, Catherine Cusack directly holds 82,847 stock units of Sabra common stock, as reported in the Form 4 filing.

What portion of Catherine Cusack’s SBRA stock units are unvested or deferred?

Her holdings include 7,027 unvested stock units and 47,553 stock units that have vested but for which payment has been deferred, according to the filing footnotes.

What does each stock unit reported by SBRA represent?

Each stock unit represents the right to receive one share of Sabra Health Care REIT, Inc. common stock, as stated in the Form 4 footnotes.

Were the 791 SBRA stock units purchased in the market?

No. The 791 stock units were credited as dividend equivalent payments on previously granted stock units, with a reported price of $0.00 per unit, rather than being purchased in the market.

Was this SBRA Form 4 transaction made under a Rule 10b5-1 trading plan?

The filing’s Rule 10b5-1 checkbox is not marked as affirmative, and no footnote states that the transaction was made under a Rule 10b5-1 trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/02/2026 - 05:36 PM Accepted by SEC EDGAR 09/02/2026 - 05:35 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cusack Catherine

(Last) (First) (Middle)

C/O SABRA HEALTH CARE REIT, INC.

1781 FLIGHT WAY

(Street)

TUSTIN CALIFORNIA 92782

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Sabra Health Care REIT, Inc. [ SBRA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/31/2026		A		791(1)	A	$0	82,847(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate.

2. Includes 7,027 unvested stock units and 47,553 stock units that have vested but the payment of which has been deferred. Each stock unit represents the right to receive one share of the Issuer's Common Stock.

Remarks:

	/s/ Michael Costa, as Attorney-in-Fact	09/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)